12 Stocks Insiders are Buying Now
In this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks thatin...
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
| 10.36 | |
| 10.57 | |
| - | |
| 10.93 | |
| 10.02 | |
| 5.99-12.35 | |
| 509 M | |
| 49 543 K | |
| 0 | |
| -0.4 | |
| 0.373 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
In this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks thatin...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: